Follow up of serial urea breath test results in patients after consumption of antibiotics for non-gastric infections
Open Access
- 1 January 2002
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 8 (4), 703-706
- https://doi.org/10.3748/wjg.v8.i4.703
Abstract
AIM: The widespread use of antibacterial therapy has been suggested to be the cause for the decline in the prevalence of Helicobacter pylori infection. This study examine the serial changes of urea breath test results in a group of hospitalized patients who were given antibacterial therapy for non-gastric infections. METHODS: Thirty-five hospitalized patients who were given antibacterial therapy for clinical infections, predominantly chest and urinary infections, were studied. Most (91%) patients were given single antibiotic of either a penicillin or cephalosporin group. Serial 13C-urea breath tests were performed within 24 h of initiation of antibiotics, at one-week and at six-week post-therapy. H. pylori infection was diagnosed when one or more urea breath tests was positive. RESULTS: All 35 patients completed three serial urea breath tests and 26 (74%) were H. pylori-positive. Ten (38%) H. pylori-infected patients had at least one negative breath test results during the study period. The medium delta 13C values were significantly lower at baseline (8.8) than at one-week (20.3) and six-week (24.5) post-treatment in H. pylori-positive individuals (P = 0.022). Clearance of H. pylori at six-week was only seen in one patient who had received anti-helicobacter therapy from another source. CONCLUSION: Our results suggested that one-third of H. pylori-infected individuals had transient false-negative urea breath test results during treatment with antibacterial agent. However, clearance of H. pylori infection by regular antibiotic consumption is rare.Keywords
This publication has 15 references indexed in Scilit:
- Comparison of two new rapid serology tests for diagnois of Helicobacter pylori infection in Chinese patientsDigestive and Liver Disease, 2002
- Pattern of Primary Resistance of Helicobacter pylori to Metronidazole or Clarithromycin in the United StatesArchives of Internal Medicine, 2001
- Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from KoreaJournal of Antimicrobial Chemotherapy, 2001
- Risk for gastric cancer after antibiotic prophylaxis in patients undergoing hip replacement.2000
- Clarithromycin for Helicobacter pylori infectionExpert Opinion on Pharmacotherapy, 2000
- Estimates of the worldwide mortality from 25 cancers in 1990International Journal of Cancer, 1999
- Epidemiology and mechanism of antibiotic resistance inGastroenterology, 1998
- Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group.Gut, 1997
- NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer DiseaseJAMA, 1994
- UNIDENTIFIED CURVED BACILLI IN THE STOMACH OF PATIENTS WITH GASTRITIS AND PEPTIC ULCERATIONThe Lancet, 1984